Abstract

Bacille Calmette–Guérin (BCG) immunization provides variable protection against tuberculosis. Prenatal antigen exposure may have lifelong effects on responses to related antigens and pathogens. We therefore hypothesized that maternal latent Mycobacterium tuberculosis infection (LTBI) influences infant responses to BCG immunization at birth. We measured antibody (n = 53) and cellular (n = 31) responses to M. tuberculosis purified protein derivative (PPD) in infants of mothers with and without LTBI, in cord blood and at one and six weeks after BCG. The concentrations of PPD-specific antibodies declined between birth (median [interquartile range (IQR)]) 5600 ng ml−1 [3300–11 050] in cord blood) and six weeks (0.00 ng ml−1 [0–288]). Frequencies of PPD-specific IFN-γ-expressing CD4+T cells increased at one week and declined between one and six weeks (p = 0.031). Frequencies of IL-2- and TNF-α-expressing PPD-specific CD4+T cells increased between one and six weeks (p = 0.019, p = 0.009, respectively). At one week, the frequency of PPD-specific CD4+T cells expressing any of the three cytokines, combined, was lower among infants of mothers with LTBI, in crude analyses (p = 0.002) and after adjusting for confounders (mean difference, 95% CI −0.041% (−0.082, −0.001)). In conclusion, maternal LTBI was associated with lower infant anti-mycobacterial T-cell responses immediately following BCG immunization. These findings are being explored further in a larger study.

Highlights

  • Bacille Calmette –Guerin (BCG) is the only vaccine against tuberculosis (TB) currently available, but its protective efficacy varies between populations

  • One hypothesis that has been advanced to explain the variability in BCG efficacy, and its relationship to latitude, is that sensitization to non-tuberculous mycobacteria (NTM), which is more common in lower latitudes [5], modifies the protection induced by BCG [6]

  • We present results of a pilot study to investigate the progression of immune responses to mycobacterial antigen, and the relationship between maternal infection with M. tuberculosis and infant immune responses, following BCG immunization at birth

Read more

Summary

Introduction

Bacille Calmette –Guerin (BCG) is the only vaccine against tuberculosis (TB) currently available, but its protective efficacy varies between populations. We present results of a pilot study to investigate the progression of immune responses to mycobacterial antigen, and the relationship between maternal infection with M. tuberculosis and infant immune responses, following BCG immunization at birth. Mothers were asked to return to the clinic one week after deliv- 2 ery At this time, a maternal blood sample was obtained for investigation of LTBI by T-SPOT.TB assay (Oxford Immunotec, Abingdon, UK) and a tuberculin skin test (TST; 2 tuberculin units, Statens Serum Institut, Copenhagen, Denmark) was performed. A maternal blood sample was obtained for investigation of LTBI by T-SPOT.TB assay (Oxford Immunotec, Abingdon, UK) and a tuberculin skin test (TST; 2 tuberculin units, Statens Serum Institut, Copenhagen, Denmark) was performed This was read between 48 and 72 h later and was defined as positive if greater than or equal to 10 mm in diameter. Results from regression analyses were presented as crude and adjusted mean difference (95% CI). p-Values of less than 0.05 were considered statistically significant

Results
Discussion
Findings
23. Gagneur A et al 2008 Kinetics of decline of maternal
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call